$ASII
Accredited Solutions, Inc. Stock $asii

$asii Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-K Financial Statement

#000147793223005374 Filed on July 18, 2023

Income Statement

Concept	2022 Q4	2022
Revenue		$483.0K
YoY Change		-60.47%
Cost Of Revenue		$387.9K
YoY Change		-65.43%
Gross Profit		$95.13K
YoY Change		-4.76%
Gross Profit Margin		19.69%
Selling, General & Admin		$275.2K
YoY Change		-54.2%
% of Gross Profit		289.3%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$26.24K
YoY Change		23.56%
% of Gross Profit		27.58%
Operating Expenses		$301.4K
YoY Change		-87.22%
Operating Profit		-$206.3K
YoY Change		-90.86%
Interest Expense		$783.2K
YoY Change		188.15%
% of Operating Profit
Other Income/Expense, Net		$235.9K
YoY Change		-109.5%
Pretax Income		$29.60K
YoY Change		-100.62%
Income Tax		$0.00
% Of Pretax Income		0.0%
Net Earnings		-$31.69K
YoY Change		-99.34%
Net Earnings / Revenue		-6.56%
Basic Earnings Per Share
Diluted Earnings Per Share		$0.00
COMMON SHARES
Basic Shares Outstanding	282.7M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments		$1.420K
YoY Change		-90.61%
Cash & Equivalents	$35.97K
Short-Term Investments
Other Short-Term Assets		$268.7K
YoY Change
Inventory	$0.00
Prepaid Expenses	$2.422K
Receivables	$51.22K	$51.22K
Other Receivables		$0.00
Total Short-Term Assets	$321.3K	$321.3K
YoY Change	1349.19%	422.98%
LONG-TERM ASSETS
Property, Plant & Equipment	$86.45K	$86.45K
YoY Change	-29.71%	-29.71%
Goodwill	$302.2K
YoY Change	0.0%
Intangibles	$105.0K
YoY Change	-6.25%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$493.7K	$493.7K
YoY Change		-8.11%
TOTAL ASSETS
Total Short-Term Assets	$321.3K	$321.3K
Total Long-Term Assets	$493.7K	$493.7K
Total Assets	$815.0K	$815.0K
YoY Change	3575.7%	36.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$104.9K	$104.9K
YoY Change	33.31%	33.31%
Accrued Expenses	$3.751K	$593.1K
YoY Change	-59.25%	223.34%
Deferred Revenue
YoY Change
Short-Term Debt		$954.0K
YoY Change		-41.54%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.690M	$4.690M
YoY Change	-8.3%	-8.3%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities		$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.690M	$4.690M
Total Long-Term Liabilities		$0.00
Total Liabilities	$4.690M	$4.690M
YoY Change	-8.3%	-7.86%
SHAREHOLDERS EQUITY
Retained Earnings	-$6.385M
YoY Change	15962600.0%
Common Stock	$339.3K
YoY Change	231.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.875M	-$3.875M
YoY Change
Total Liabilities & Shareholders Equity	$815.0K	$815.0K
YoY Change	3575.7%	36.14%

Cashflow Statement

Concept	2022 Q4	2022
OPERATING ACTIVITIES
Net Income		-$31.69K
YoY Change		-99.34%
Depreciation, Depletion And Amortization		$26.24K
YoY Change		23.56%
Cash From Operating Activities		-$233.5K
YoY Change		-67.91%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$14.33K
YoY Change		-102.23%
Cash From Investing Activities		$14.33K
YoY Change		-102.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		$235.0K
YoY Change		-82.89%
NET CHANGE
Cash From Operating Activities		-$233.5K
Cash From Investing Activities		$14.33K
Cash From Financing Activities		$235.0K
Net Change In Cash		$15.81K
YoY Change		-135.33%
FREE CASH FLOW
Cash From Operating Activities		-$233.5K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	us-gaap	Gross Profit GrossProfit	0	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	0	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	387909	usd
CY2022	us-gaap	Gross Profit GrossProfit	95127	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	275204	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	26240	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	301444	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-206317	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3751	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	455825	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	529887	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2838278	usd
CY2022	us-gaap	Revenues Revenues	483036	usd
CY2021	us-gaap	Revenues Revenues	0	usd
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001464865
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	30000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	14000	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	102500000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	339277449	shares
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-54509
CY2022	dei	Entity Registrant Name EntityRegistrantName	Accredited Solutions, Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-2578051
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	20311 Chartwell Center Drive
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1469
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Cornelius
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	28031
CY2022	dei	City Area Code CityAreaCode	800
CY2022	dei	Local Phone Number LocalPhoneNumber	947-9197
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	339398	usd
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	678796778	shares
CY2022	dei	Auditor Name AuditorName	Victor Mokuolu, CPA PLLC
CY2022	dei	Auditor Location AuditorLocation	Houston, Texas
CY2022	dei	Auditor Firm AuditorFirmId	6771
CY2022Q4	us-gaap	Cash Cash	1418	usd
CY2021Q4	us-gaap	Cash Cash	0	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	51224	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0	usd
CY2022Q4	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	266251	usd
CY2021Q4	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	22172	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	104939	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	0	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	133494	usd
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	0	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	29100	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	0	usd
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0	usd
CY2022Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	395000	usd
CY2021Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	0	usd
CY2022Q4	ghmp	Current Liabilities Held For Sale CurrentLiabilitiesHeldForSale	200149	usd
CY2021Q4	ghmp	Current Liabilities Held For Sale CurrentLiabilitiesHeldForSale	0	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4690423	usd
CY2022Q4	us-gaap	Liabilities Liabilities	4690423	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	30000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	14000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	14	usd
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	102500000	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	339277	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2170342	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6385080	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3875447	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	814976	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	0	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	0	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	0	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	0	usd
CY2022	ghmp	Change In Derivative Liabilities ChangeInDerivativeLiabilities	2189161	usd
CY2021	ghmp	Change In Derivative Liabilities ChangeInDerivativeLiabilities	0	usd
CY2022	us-gaap	Legal Fees LegalFees	13806	usd
CY2021	us-gaap	Legal Fees LegalFees	0	usd
CY2022	ghmp	Loss On Impairment Of Intangible Assets LossOnImpairmentOfIntangibleAssets	-7000	usd
CY2021	ghmp	Loss On Impairment Of Intangible Assets LossOnImpairmentOfIntangibleAssets	0	usd
CY2022	ghmp	Net Loss Per Share From Continuing Operations Basic And Diluted NetLossPerShareFromContinuingOperationsBasicAndDiluted	0.00
CY2021	ghmp	Net Loss Per Share From Continuing Operations Basic And Diluted NetLossPerShareFromContinuingOperationsBasicAndDiluted	-0.00
CY2022	ghmp	Net Loss Per Share From Discontinued Operations Basic And Diluted NetLossPerShareFromDiscontinuedOperationsBasicAndDiluted	-0.00
CY2021	ghmp	Net Loss Per Share From Discontinued Operations Basic And Diluted NetLossPerShareFromDiscontinuedOperationsBasicAndDiluted	0.00
CY2022	ghmp	Net Loss Per Share Basic And Diluted NetLossPerShareBasicAndDiluted	-0.00
CY2021	ghmp	Net Loss Per Share Basic And Diluted NetLossPerShareBasicAndDiluted	-0.00
CY2022	ghmp	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	189662591	shares
CY2021	ghmp	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	10158356	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	2202	usd
CY2021	ghmp	Issuance Of Common Stock For Cash Amount IssuanceOfCommonStockForCashAmount	10000	usd
CY2021	ghmp	Issuance Of Common Stock For Exercise Of Warrant Amount IssuanceOfCommonStockForExerciseOfWarrantAmount	10000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-30	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	22172	usd
CY2022	ghmp	Issuance Of Common Stock For Cash Amount IssuanceOfCommonStockForCashAmount	120000	usd
CY2022	ghmp	Cancellation Of Common Stock Amount CancellationOfCommonStockAmount	0	usd
CY2022	ghmp	Reverse Merger Acquisition Amount ReverseMergerAcquisitionAmount	-6226462	usd
CY2022	ghmp	Conversion Of Common Stock Into Preferred Stock Amount ConversionOfCommonStockIntoPreferredStockAmount	0	usd
CY2022	ghmp	Issuance Of Preferred Stock For Servicesamount IssuanceOfPreferredStockForServicesamount	10778	usd
CY2022	ghmp	Issuance Of Common Stock For Conversion Of Note Payable Amount IssuanceOfCommonStockForConversionOfNotePayableAmount	2264308	usd
CY2022	ghmp	Issuance Of Common Stock For Sponsorship Agreement Amount IssuanceOfCommonStockForSponsorshipAgreementAmount	21000	usd
CY2022	ghmp	Warrants Issued For Commitment Fee WarrantsIssuedForCommitmentFee	-55555	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-31688	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3875447	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-31688	usd
CY2022	ghmp	Net Income Loss From Discontinued Operations NetIncomeLossFromDiscontinuedOperations	61289	usd
CY2021	ghmp	Net Income Loss From Discontinued Operations NetIncomeLossFromDiscontinuedOperations	30	usd
CY2022	us-gaap	Depreciation Depreciation	26240	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	10778	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2021	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	0	usd
CY2022	ghmp	Impairment Of Intangible Assets ImpairmentOfIntangibleAssets	7000	usd
CY2021	ghmp	Impairment Of Intangible Assets ImpairmentOfIntangibleAssets	0	usd
CY2022	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-2189161	usd
CY2021	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	0	usd
CY2022	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-47678	usd
CY2021	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	0	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	0	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	23559	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	0	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1636	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	0	usd
CY2022	ghmp	Interest Payable InterestPayable	782182	usd
CY2021	ghmp	Interest Payable InterestPayable	0	usd
CY2022	ghmp	Interest Payable To Related Parties InterestPayableToRelatedParties	22438	usd
CY2021	ghmp	Interest Payable To Related Parties InterestPayableToRelatedParties	0	usd
CY2022	ghmp	Operating Cash Flows From Discontinued Operations OperatingCashFlowsFromDiscontinuedOperations	-90829	usd
CY2021	ghmp	Operating Cash Flows From Discontinued Operations OperatingCashFlowsFromDiscontinuedOperations	-30	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-233526	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-30	usd
CY2022	ghmp	Net Funds Received With Acquisition Of Subsidiary NetFundsReceivedWithAcquisitionOfSubsidiary	14334	usd
CY2021	ghmp	Net Funds Received With Acquisition Of Subsidiary NetFundsReceivedWithAcquisitionOfSubsidiary	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	14334	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	125000	usd
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2022	ghmp	Financing Activities Of Discontinued Operations FinancingActivitiesOfDiscontinuedOperations	110000	usd
CY2021	ghmp	Financing Activities Of Discontinued Operations FinancingActivitiesOfDiscontinuedOperations	20000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	235000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	20000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	15808	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	19970	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20160	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	190	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35968	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20160	usd
CY2022	ghmp	Cash And Cash Equivalents Of Discontinued Operations CashAndCashEquivalentsOfDiscontinuedOperations	-34550	usd
CY2021	ghmp	Cash And Cash Equivalents Of Discontinued Operations CashAndCashEquivalentsOfDiscontinuedOperations	-20160	usd
CY2022	ghmp	Cash And Cash Equivalents Of Discontinued Operations Ending Balance CashAndCashEquivalentsOfDiscontinuedOperationsEndingBalance	1418	usd
CY2021	ghmp	Cash And Cash Equivalents Of Discontinued Operations Ending Balance CashAndCashEquivalentsOfDiscontinuedOperationsEndingBalance	0	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	883	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	ghmp	Conversion Of Common Stock Into Preferred Stock Non Cash ConversionOfCommonStockIntoPreferredStockNonCash	33167	usd
CY2021	ghmp	Conversion Of Common Stock Into Preferred Stock Non Cash ConversionOfCommonStockIntoPreferredStockNonCash	0	usd
CY2022	ghmp	Spire Sponsorship Agreement For Common Stock SpireSponsorshipAgreementForCommonStock	21000	usd
CY2021	ghmp	Spire Sponsorship Agreement For Common Stock SpireSponsorshipAgreementForCommonStock	0	usd
CY2022	ghmp	Conversion Of Preferred Stock Into Common Stock ConversionOfPreferredStockIntoCommonStock	1115043	usd
CY2021	ghmp	Conversion Of Preferred Stock Into Common Stock ConversionOfPreferredStockIntoCommonStock	0	usd
CY2022	us-gaap	Nature Of Operations NatureOfOperations	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 1 – NATURE OF OPERATIONS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accredited Solutions, Inc. (the “Company” or “Accredited”), formerly known as Keyser Resources, Inc., Lone Star Gold, Inc. and Good Hemp, Inc., was incorporated in the State of Nevada on November 26, 2007.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company was involved in the exploration and development of mining properties until September 30, 2013, when it discontinued operations. In 2017, the Company was put into receivership and, in 2018, it emerged from receivership. On September 12, 2019, the Company’s corporate name changed to Good Hemp, Inc.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On April 1, 2021, the Company entered into an agreement to purchase Diamond Creek Group, LLC, a North Carolina limited liability company which sells the Diamond Creek brand of high alkaline water products, for a total purchase price of $643,000. On April 2, 2021, the Company closed the acquisition and paid the initial $500,000 portion of the purchase price, and on April 23, 2021, paid the $143,000 purchase price balance.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Effective May 11, 2022, the Company completed a Plan and Agreement of Merger (the “PXS Merger Agreement”) with Petro X Solutions, Inc., a Wyoming corporation (“PXS”), with PXS becoming our wholly-owned subsidiary as a result of the PXS Merger. Pursuant to the PXS Merger Agreement, as amended, an aggregate of 120,000,000 shares of Company common stock were issued to the shareholders of PXS in the PXS Merger. PXS markets competitively-priced, environmentally-friendly products that are designed to work as well as or better than their toxic competitors.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Effective June 1, 2023, the PXS Merger was rescinded, such that all securities issued by the Company in connection with the PXS Merger were cancelled and the ownership of PXS returned to its prior owners.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">PXS is being treated as discontinued operations in the consolidated financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s operations are centered on those of Diamond Creek Group and its bottled water products.</p>
CY2021Q4	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	643000	usd
CY2021Q2	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	500000	usd
CY2021Q2	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	143000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the recoverability of long-lived assets and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</p>
CY2022Q4	ghmp	Working Capital Deficit WorkingCapitalDeficit	4369108	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-31688	usd
CY2022	us-gaap	Proceeds From Operating Activities ProceedsFromOperatingActivities	233526	usd
CY2019Q1	ghmp	Preferred Stock Shares Issued For Acquisitions PreferredStockSharesIssuedForAcquisitions	12000	shares
CY2019Q1	ghmp	Total Value Of Preferred Stock Shares TotalValueOfPreferredStockShares	12000	usd
CY2019Q2	ghmp	Related Inventory Consideration RelatedInventoryConsideration	32462	usd
CY2020Q1	ghmp	Shares Issued Upon Agreement SharesIssuedUponAgreement	6000000	shares
CY2021Q2	ghmp	Acquisition Paid Initial Portion Of Purchase Price AcquisitionPaidInitialPortionOfPurchasePrice	643000	usd
CY2021Q2	ghmp	Acquisition Paid Initial Portion Of Purchase Price AcquisitionPaidInitialPortionOfPurchasePrice	500000	usd
CY2021Q2	ghmp	Acquisition Paid Initial Portion Of Purchase Price AcquisitionPaidInitialPortionOfPurchasePrice	143000	usd
CY2022Q4	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	643000	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	38635	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables	41611	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	97228	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	100000	usd
CY2022Q4	ghmp	Assets Acquired AssetsAcquired	277474	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	77998	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	20000	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	97998	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	463524	usd
CY2022Q4	us-gaap	Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount	161309	usd
CY2022Q4	us-gaap	Goodwill Goodwill	302215	usd
CY2022	us-gaap	Impairment Charge On Reclassified Assets ImpairmentChargeOnReclassifiedAssets	7000	usd
CY2022	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	5000	usd
CY2020Q2	us-gaap	Legal Fees LegalFees	80000	usd
CY2019Q3	ghmp	Converted Description ConvertedDescription	The number of shares which will be issued upon any conversion of the notes will be determined by dividing the principal amount to be converted (plus, at the option of the noteholder, accrued and unpaid interest) by the lower of (i) $0.001 or, (ii) 50% of the lowest bid price during the forty-five consecutive trading day period ending on the trading day immediately prior to the conversion date.
CY2022Q2	ghmp	Common Stock Shares Authorized Designating Shares CommonStockSharesAuthorizedDesignatingShares	100000000	shares
CY2022	ghmp	Conversion Of Common Stock Into Preferred Stock Shares ConversionOfCommonStockIntoPreferredStockShares	-33166670	shares
CY2022	ghmp	Schedule Of Summary Purchases Towards Related Party ScheduleOfSummaryPurchasesTowardsRelatedParty	<table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exchange Agreement</strong></p></td><td style="width:1%;"></td><td style="BORDER-BOTTOM: 1px solid;width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of Shares of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Common Stock Exchanged</strong></p></td><td style="width:1%;"></td><td style="BORDER-BOTTOM: 1px solid;width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of Shares of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Series A Preferred Stock Issued</strong></p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Deneault Agreement</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">14,083,330 shares</p></td><td></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">5,500 shares</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Newlan Agreement</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">14,083,340 shares</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">5,500 shares</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Sluss Agreement</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">5,000,000 shares</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2,000 shares</p></td></tr></tbody></table>
CY2022Q4	ghmp	Common Stock Shares Cancel CommonStockSharesCancel	33166670	shares
CY2022	ghmp	Common Stock Shares Authorized Designating Shares CommonStockSharesAuthorizedDesignatingShares	5000	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P1Y
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.9038	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0473	pure
CY2022Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	2838278	usd
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2022Q2	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	300000	shares
CY2022Q2	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	120000	usd
CY2022Q2	ghmp	Stock Issued During Period Shares Cancelled StockIssuedDuringPeriodSharesCancelled	550000	shares
CY2022Q4	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	33166670	shares
CY2022Q4	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	1000	shares
CY2022Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	10777	usd
CY2022	ghmp	Debt Conversion Shares DebtConversionShares	5555555	shares
CY2022	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	0.009
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	ghmp	Reconciliation Of The Provision For Income Taxes Table Te Block ReconciliationOfTheProvisionForIncomeTaxesTableTeBlock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Income tax (payable) recovery at statutory rate of 21%</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(6,654)</p></td><td style="width:1%;white-space: nowrap;"></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Valuation allowance change</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><p style="font-size:10pt;font-family:times new roman;margin:0px">6,654</p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">6</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Provision for income taxes</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-6654	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-6	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	6654	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	6	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	34550	usd
CY2021Q4	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	20160	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Inventory Current DisposalGroupIncludingDiscontinuedOperationInventoryCurrent	91	usd
CY2021Q4	us-gaap	Disposal Group Including Discontinued Operation Inventory Current DisposalGroupIncludingDiscontinuedOperationInventoryCurrent	2012	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Prepaid And Other Assets Current DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent	231610	usd
CY2021Q4	us-gaap	Disposal Group Including Discontinued Operation Prepaid And Other Assets Current DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent	0	usd
CY2022Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	266251	usd
CY2021Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	22172	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Accounts Payable Current DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent	200149	usd
CY2021Q4	us-gaap	Disposal Group Including Discontinued Operation Accounts Payable Current DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent	0	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	200149	usd
CY2021Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	250	usd
CY2021	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	0	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	7329	usd
CY2021	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	0	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Gross Profit Loss DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss	-7079	usd
CY2021	us-gaap	Disposal Group Including Discontinued Operation Gross Profit Loss DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss	0	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation General And Administrative Expense DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense	54210	usd
CY2021	us-gaap	Disposal Group Including Discontinued Operation General And Administrative Expense DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense	30	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	54210	usd
CY2021	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	30	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-61289	usd
CY2021	us-gaap	Income Loss From Individually Significant Component Disposed Of Or Held For Sale Excluding Discontinued Operations Before Income Tax IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax	-30	usd
CY2022	us-gaap	Income Loss From Individually Significant Component Disposed Of Or Held For Sale Excluding Discontinued Operations Before Income Tax IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax	-61289	usd
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-30	usd
CY2021	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	0	usd
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	0	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-61289	usd
CY2021	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-30	usd
CY2022	ghmp	Net Income Loss Of Discontinued Operations NetIncomeLossOfDiscontinuedOperations	-61289	usd
CY2020	ghmp	Net Income Loss Of Discontinued Operations NetIncomeLossOfDiscontinuedOperations	-30	usd
CY2022	ghmp	Discontinued Operation Increase Decrease In Inventories DiscontinuedOperationIncreaseDecreaseInInventories	1920	usd
CY2022	ghmp	Proceeds From Exercise Of Warrants For Common Stock Discontinued Operations ProceedsFromExerciseOfWarrantsForCommonStockDiscontinuedOperations	0	usd
CY2022	ghmp	Discontinued Operation Increase Decrease In Prepaid Expenses Other Current Assets DiscontinuedOperationIncreaseDecreaseInPrepaidExpensesOtherCurrentAssets	-231610	usd
CY2020	ghmp	Discontinued Operation Increase Decrease In Inventories DiscontinuedOperationIncreaseDecreaseInInventories	0	usd
CY2022	ghmp	Discontinued Operation Increase Decrease In Accounts Payable And Accrued Liabilities DiscontinuedOperationIncreaseDecreaseInAccountsPayableAndAccruedLiabilities	200150	usd
CY2020	ghmp	Discontinued Operation Increase Decrease In Prepaid Expenses Other Current Assets DiscontinuedOperationIncreaseDecreaseInPrepaidExpensesOtherCurrentAssets	0	usd
CY2022	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-90829	usd
CY2020	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-30	usd
CY2022	ghmp	Proceeds From Issuance Of Common Stock Discontinued Operations ProceedsFromIssuanceOfCommonStockDiscontinuedOperations	110000	usd
CY2020	ghmp	Proceeds From Issuance Of Common Stock Discontinued Operations ProceedsFromIssuanceOfCommonStockDiscontinuedOperations	10000	usd
CY2020	ghmp	Discontinued Operation Increase Decrease In Accounts Payable And Accrued Liabilities DiscontinuedOperationIncreaseDecreaseInAccountsPayableAndAccruedLiabilities	0	usd
CY2020	ghmp	Proceeds From Exercise Of Warrants For Common Stock Discontinued Operations ProceedsFromExerciseOfWarrantsForCommonStockDiscontinuedOperations	10000	usd
CY2022	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	110000	usd
CY2020	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	20000	usd

Files In Submission

Name	View Source	Status
0001477932-23-005374-index-headers.html	Edgar Link	pending
0001477932-23-005374-index.html	Edgar Link	pending
0001477932-23-005374.txt	Edgar Link	pending
0001477932-23-005374-xbrl.zip	Edgar Link	pending
accredited_10k.htm	Edgar Link	pending
accredited_10kimg3.jpg	Edgar Link	pending
accredited_10kimg5.jpg	Edgar Link	pending
accredited_ex311.htm	Edgar Link	pending
accredited_ex312.htm	Edgar Link	pending
accredited_ex321.htm	Edgar Link	pending
accredited_ex322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
accredited_10k_htm.xml	Edgar Link	completed
ghmp-20221231.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
ghmp-20221231_def.xml	Edgar Link	unprocessable
ghmp-20221231_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending
ghmp-20221231_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ghmp-20221231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ASII
Accredited Solutions, Inc. Stock $asii

2022 Q4 Form 10-K Financial Statement

#000147793223005374 Filed on July 18, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ASII Accredited Solutions, Inc. Stock $asii

2022 Q4 Form 10-K Financial Statement

#000147793223005374 Filed on July 18, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ASII
Accredited Solutions, Inc. Stock $asii